Impact of universal immunohistochemistry on Lynch syndrome diagnosis in an Australian colorectal cancer cohort.

Universal IHC testing may increase the detection of LS, and should be implemented where possible. However, the full benefit was limited by low referral to and uptake of genetic testing, and further strategies are needed to overcome these barriers.